GPT and metabolic dysfunction-associated steatotic liver disease: AST/ALT ratio, NAFLD fibrosis score, FIB-4 index and Hepamet fibrosis score, and PDGFRβ + FIB-4 were significantly higher in diabetic MAFLD patients compared to the nondiabetics, while both APRI and King’s score had no significant difference between MAFLD subgroups (Table 5).